-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2020 to Q4 2023.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was -$401K, a 67.3% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)